Cargando…

Use of Impella heart pump for management of women with peripartum cardiogenic shock

BACKGROUND: Percutaneous mechanical circulatory support (MCS), such as the Impella heart pump is a valuable option for cardiogenic shock (CS), although the use of Impella in CS due to peripartum cardiomyopathy (PPCM) is limited. OBJECTIVE: To assess outcomes in women with PPCM supported with an Impe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elkayam, Uri, Schäfer, Andreas, Chieffo, Alaide, Lansky, Alexandra, Hall, Shelley, Arany, Zoltan, Grines, Cindy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788473/ https://www.ncbi.nlm.nih.gov/pubmed/31436333 http://dx.doi.org/10.1002/clc.23249

Ejemplares similares

Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry
por: Botti, Giulia, et al.
Publicado: (2022)

Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Racial and Ethnic Disparities in the Trends and Outcomes of Cardiogenic Shock Complicating Peripartum Cardiomyopathy
por: Olanipekun, Titilope, et al.
Publicado: (2022)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry
por: O’Neill, William W, et al.
Publicado: (2014)

Electrocardiographic findings in peripartum cardiomyopathy
por: Honigberg, Michael C., et al.
Publicado: (2019)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Trends in Veno‐Arterial Extracorporeal Life Support With and Without an Impella or Intra‐Aortic Balloon Pump for Cardiogenic Shock
por: Hendrickson, Michael J., et al.
Publicado: (2022)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Defining the optimal revascularization strategy during protected high-risk procedures with Impella
por: Sinning, Jan-Malte, et al.
Publicado: (2022)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Cardiogenic shock in thyroid storm: A biventricular impella (Bi‐Pella) approach
por: Caruso, Evan, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Subclinical Aortic Insufficiency Causing Cardiogenic Shock Years After Impella Placement
por: Syed, Ali, et al.
Publicado: (2023)

Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery
por: Sicouri, Serge, et al.
Publicado: (2023)

Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience
por: Schwartz, Bryan G., et al.
Publicado: (2012)

Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump
por: Schroeter, Marco R., et al.
Publicado: (2012)

Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry
por: Iannaccone, Mario, et al.
Publicado: (2023)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Pseudoaneurysm Formation After “Preclose”-Assisted Impella Insertion in a Patient With Cardiogenic Shock
por: Asemota, Daniel, et al.
Publicado: (2022)

Use of Extracorporeal Membrane Oxygenation and Impella as Bridge to Surgery Through Imaging for Cardiogenic Shock
por: Anastasius, Malcolm, et al.
Publicado: (2022)

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
por: Saito, Yuichi, et al.
Publicado: (2023)

To Breastfeed or Not to Breastfeed With Peripartum Cardiomyopathy
por: Arany, Zoltan, et al.
Publicado: (2019)

Impellent impeller—Switching intra‐aortic balloon pump to IMPELLA‐CP after ST‐segment elevation myocardial infarction and refractory cardiogenic shock
por: Contarini, Marco, et al.
Publicado: (2019)

Recurrent Stress-Induced Cardiomyopathy With Cardiogenic Shock Requiring Impella Left Ventricular Assist Device
por: Feghaly, Julien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l8trskq8nkti22nau4rc716m4f